Biomarkers for immunotherapy for treatment of glioblastoma

Immunotherapy is a promising new therapeutic field that has demonstrated significant benefits in many solid-tumor malignancies, such as metastatic melanoma and non-small cell lung cancer. However, only a subset of these patients responds to treatment. Glioblastoma (GBM) is the most common malignant...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Lynes, John P, Nwankwo, Anthony K, Sur, Hannah P, Sanchez, Victoria E, Sarpong, Kwadwo A, Ariyo, Oluwatobi I, Dominah, Gifty A, Nduom, Edjah K
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264836/
https://ncbi.nlm.nih.gov/pubmed/32474411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000348
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items